logo
Willis Knighton Health officials open new Nuclear Oncology Department in Shreveport

Willis Knighton Health officials open new Nuclear Oncology Department in Shreveport

Yahoo02-04-2025
Dr. Saul Hertz administered the first distribution of radioactive iodine on March 31, 1941, in Boston. In honor of that groundbreaking invention, a local hospital launched its new cancer center on World Theranostics Day.
Willis Knight Health in Shreveport welcomed the first Nuclear Oncology Department to northwest Louisiana on the 84th anniversary.
"The opening of the nuclear oncology department expands the options for cancer treatment in our community," Jaf Fielder, president and CEO of Willis Knighton Health said.
"This is yet another in a long list of new advanced technologies to enhance cancer treatment for patients at Willis Knighton," Fielder said.
The Cancer Center at Willis Knighton has undergone a $7-million expansion that includes the addition of the newest and most advanced molecular imaging tools in the country.
It has added a second PET/CT scanner and the first GE HealthCare StarGuide SPECT/CT system in Louisiana.
'StarGuide SPECT/CT's innovative technology is a significant contribution to oncology care at Willis Knighton Cancer Center,' said Dr. Ilya Gipp, global clinical oncology leader, GE HealthCare.
The StarGuide SPECT/CT system combines a nuclear medicine single photon emission computed tomography system and a computed tomography system. The system's 12 CZT detector design not only scans patients in 3D to provide more information to clinicians but also is optimized for certain theragnostic procedures, which in turn helps clinicians pinpoint the size, shape and position of lesions with exceptional accuracy.
scan is performed to monitor treatment
isotope is injected to selectively destroy cancer cells
This level of precision reduces the affected area and lessens the risk for side effects.
According to Willis Knighton, this type of scan provides physicians with data to assist in diagnosing, treating and monitoring cancer therapy.
Makenzie Boucher is a reporter with the Shreveport Times. Contact her at mboucher@gannett.com.
This article originally appeared on Shreveport Times: Willis Knighton Health opens Nuclear Oncology Department in Shreveport
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Global Non-invasive Brain Trauma Monitoring Device Market Size/Share Worth USD 32.19 Billion by 2034 at a 8.13% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)
Global Non-invasive Brain Trauma Monitoring Device Market Size/Share Worth USD 32.19 Billion by 2034 at a 8.13% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)

Yahoo

time11 hours ago

  • Yahoo

Global Non-invasive Brain Trauma Monitoring Device Market Size/Share Worth USD 32.19 Billion by 2034 at a 8.13% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Non-invasive Brain Trauma Monitoring Device Market size & share revenue was valued at approximately USD 14.7 Billion in 2024 and is expected to reach USD 14.98 Billion in 2025 and is expected to reach around USD 32.19 Billion by 2034, at a CAGR of 8.13% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Natus Medical Inc., Philips Healthcare, Nihon Kohden Corporation, GE Healthcare, CAS Medical Systems Inc. (Edwards Lifesciences Corporation), Advanced Brain Monitoring, Siemens AG, Medtronic Plc., Compumedics Ltd., Integra LifeSciences, Covidien PLC, Sophysa, Spiegelberg GmbH & Co. KG, Hitachi Medical Corporation, NeuroLogica Corp., NeuroWave Systems Inc., Noraxon U.S.A, RAUMEDIC AG & Others. Austin, TX, USA, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled 'Non-invasive Brain Trauma Monitoring Device Market Size, Trends and Insights By Product Type (Monitoring Devices, Consumables), By End-User (Hospitals, Neurological Centres, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034' in its research database.'According to the latest research study, the demand of the global Non-invasive Brain Trauma Monitoring Device Market size & share was valued at approximately USD 14.7 Billion in 2024 and is expected to reach USD 14.98 Billion in 2025 and is expected to reach a value of around USD 32.19 Billion by 2034, at a compound annual growth rate (CAGR) of about 8.13% during the forecast period 2025 to 2034.' Click Here to Access a Free Sample Report of the Global Non-invasive Brain Trauma Monitoring Device Market @ Non-invasive Brain Trauma Monitoring Device Market Overview The global market for non-invasive brain trauma monitoring devices is growing quickly because more advanced diagnostic technologies are being used, which aim to reduce the need for patients to be involved in healthcare procedures. Examples of such devices include electroencephalography (EEG), near-infrared spectroscopy (NIRS), and transcranial Doppler ultrasound, which allow for noninvasive, real-time monitoring of brain activity, intracranial pressure, and other key neurologic parameters without needing surgical access. Non-invasive techniques for assessing brain function are revolutionizing neurological care by providing safer, quicker, and better diagnostic solutions, especially in emergency units, intensive care units, and neurological treatment centers. One of the key factors driving this market is the rising demand for minimally invasive healthcare procedures. The traditional invasive approach consists of placing a catheter for intracranial pressure monitoring, which carries risks of infection, bleeding, and long recovery times. Conversely, non-invasive methods offer the advantage of avoiding these associated risks, making them a painless and low-risk option for the patient. This change is part of a broader medical effort to minimize trauma and ensure prompt diagnosis. Chronic disease management has become a major focus of these healthcare devices and equipment, as they allow patients to receive timely feedback from their healthcare providers and thus allow them to manage these chronic diseases from the comfort of their homes. In addition, healthcare providers supply these devices, which improve operational efficiency, reduce hospital stay times, and lower the overall cost of healthcare. Patient education about the advantages of non-invasive monitoring and the demand for it led to notable market growth. One of the largest bottlenecks preventing such growth is the lack of trained professionals to operate these advanced devices. Many noninvasive monitoring technologies need specific expertise for appropriate use and accurate data interpretation. A lack of a properly trained workforce, especially in the developing regions, can lead to the false interpretation of results, delayed diagnoses, and poor patient outcomes. To overcome this hurdle, investment must be directed toward extensive training programs that integrate traditional learning with practical training. In addition, the integration of artificial intelligence (AI) and machine learning (ML) in this equipment can help to bridge the skills gap by reducing human error in data analysis and assisting healthcare workers in making diagnoses. AI and ML in Non-invasive Brain Trauma Monitoring Devices The implementation of AI and ML is among the most significant changes in this market. By processing large amounts of patient data in real time, AI-powered systems improve the efficiency and accuracy of neurological assessments. As machine learning algorithms learn from new data from more patients, monitoring devices become more intelligent and effective over time. Advanced automation driven by AI facilitates predictive analytics, which means that for neurological disorders, symptoms can be identified much before they even start to make any sense. It is indeed a phenomenal step forward, as it not only saves lives but also facilitates timely treatment and personalized medication. Another significant trend impacting the market is the growing adoption of telemedicine and remote patient monitoring solutions. The advent of digital healthcare has allowed doctors to remotely monitor brain health, avoiding in-person hospital visits and making neurological care available for patients without access to in-person hospitals, especially those in rural and underserved regions. The coronavirus pandemic has increased the importance of telehealth by accelerating the transition to remote health solutions that preserve continuity of care. This novel approach presents new avenues for the integration of non-invasive brain trauma monitoring into healthcare delivery, performed by coupling such devices with telemedicine platforms to relay the data they collect to healthcare providers who can provide immediate feedback and aid to the patients, regardless of their geographical proximity to the healthcare provider. This will likely lead to further advancements in non-invasive monitoring technologies, ensuring that they become increasingly more accessible and effective. End-users segment the global non-invasive brain trauma monitoring device market into hospitals, neurological centers, and others. The hospital segment is expected to dominate the global non-invasive brain trauma monitoring devices market, owing to the high number of traumatic brain injury (TBI) cases, stroke patients, and neurological emergencies that can be treated in a hospital setting. Places of diagnosis and treatment for these TBIs are primarily in hospitals, and according to the World Health Organization (WHO), TBIs account for approximately 50 million cases worldwide per year. Hospitals play a key role in acute neurological care, with more than 2.8 million presentations to US emergency departments for TBI each year. Hospitals have equipped specialized neurocritical care units, advanced imaging systems, and multidisciplinary health care teams, making it the setting of choice for brain trauma monitoring. Request a Customized Copy of the Non-invasive Brain Trauma Monitoring Device Market Report @ The non-invasive brain trauma monitoring device system market is segmented across Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America holds a leading position in the non-invasive brain trauma monitoring devices market, followed by Europe and Asia-Pacific. The U.S. dominates the market owing to the presence of key market players, a high prevalence of traumatic brain injuries, and a rising trend toward patient-centric care, which eventually aids in market growth. Europe holds a second place, which can be attributed to government initiatives supporting the implementation of non-invasive healthcare solutions, increased prevalence of neurological disorders, and a rapidly aging population that requires continuous brain monitoring. In addition, the Asia-Pacific region is expected to register the highest growth rate owing to improving healthcare facilities, increasing investment in medical equipment, and increasing awareness about brain trauma monitoring. Similarly, the Asia Pacific region is a lucrative market for the industry, with countries like China, India, and Japan actively involved in the integration of non-invasive monitoring devices in their healthcare systems. AI-driven automation, telemedicine integration, and continuous advancements in non-invasive diagnostic tools are revolutionizing neurological care and improving patient outcomes worldwide, indicating that the future of the non-invasive brain trauma monitoring devices market remains bright. Report Scope Feature of the Report Details Market Size in 2025 USD 14.98 Billion Projected Market Size in 2034 USD 32.19 Billion Market Size in 2024 USD 14.73 Billion CAGR Growth Rate 8.13% CAGR Base Year 2024 Forecast Period 2025-2034 Key Segment By Product Type, End-User and Region Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America Buying Options Request tailored purchasing options to fulfil your requirements for research. (A free sample of the Non-invasive Brain Trauma Monitoring Device report is available upon request; please contact us for more information.) Our Free Sample Report Consists of the following: The updated report for 2024 includes an Introduction, an Overview, and an in-depth industry analysis. We have included the COVID-19 Pandemic Outbreak Impact Analysis in the package. About 220+ Pages Research Report (Including Recent Research) Provide detailed chapter-by-chapter guidance on the Request. Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2025 Includes Tables and figures have been updated. The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis Custom Market Insights (CMI) research methodology (Please note that the sample of the Non-invasive Brain Trauma Monitoring Device report has been modified to include the COVID-19 impact study prior to delivery.) Request a Customized Copy of the Non-invasive Brain Trauma Monitoring Device Market Report @ CMI has comprehensively analyzed the global non-invasive brain trauma monitoring device market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict an in-depth scenario of the market. Segment-wise market size and market share during the forecast period are duly addressed to portray the probable picture of this global non-invasive brain trauma monitoring device industry. The competitive landscape includes key innovators, aftermarket service providers, market giants, and niche players. These are studied and analyzed extensively concerning their strengths, weaknesses, and value addition prospects. In addition, this report covers key player profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends, and dynamics in partnerships. Key questions answered in this report: What is the size of the Non-invasive Brain Trauma Monitoring Device market and what is its expected growth rate? What are the primary driving factors that push the Non-invasive Brain Trauma Monitoring Device market forward? What are the Non-invasive Brain Trauma Monitoring Device Industry's top companies? What are the different categories that the Non-invasive Brain Trauma Monitoring Device Market caters to? What will be the fastest-growing segment or region? In the value chain, what role do essential players play? What is the procedure for getting a free copy of the Non-invasive Brain Trauma Monitoring Device market sample report and company profiles? Key Offerings: Market Share, Size & Forecast by Revenue | 2025−2034 Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions Competitive Landscape – Top Key Vendors and Other Prominent Vendors Buy this Premium Non-invasive Brain Trauma Monitoring Device Research Report | Fast Delivery Available - [220+ Pages] @ Non-invasive Brain Trauma Monitoring Device Market Regional Analysis The non-invasive brain trauma monitoring devices market is led by North America, owing to the higher occurrence of traumatic brain injuries (TBIs), strokes, and neurodegenerative disorders observed in individuals, especially seen in the two countries, the United States and Canada. It is estimated that about 2.8 million TBIs occur per year in the U.S., resulting in 61,000 such deaths annually, according to the Centers for Disease Control and Prevention (CDC). As the baby boomer generation ages, approximately 6.7 million Americans are impacted by conditions such as Alzheimer's and other neurodegenerative diseases, which creates a need for continuous monitoring of brain function. The increasing prevalence of sports-induced concussions, road accidents, and falls among the geriatric population further supports the dominance of the region in the glimmering market. The government and private enterprises are investing billions of dollars in neurological research and development. Building on initiatives like that of the National Institute of Neurological Disorders and Stroke (NINDS) and the so-called BRAIN Initiative, there is increasing interest in developing new kinds of non-invasive brain monitoring technology to improve diagnostic, prognostic, and therapeutic outcomes. Request a Customized Copy of the Non-invasive Brain Trauma Monitoring Device Market Report @ (We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.) Still, Looking for More Information? Do you want data for inclusion in magazines, case studies, research papers, or media? Email Directly Here with Detail Information: support@ Browse the full 'Non-invasive Brain Trauma Monitoring Device Market Size, Trends and Insights By Product Type (Monitoring Devices, Consumables), By End-User (Hospitals, Neurological Centres, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034' Report at of the prominent players in the Non-invasive Brain Trauma Monitoring Device Market: Natus Medical Inc. Philips Healthcare Nihon Kohden Corporation GE Healthcare CAS Medical Systems Inc. (Edwards Lifesciences Corporation) Advanced Brain Monitoring Siemens AG Medtronic Plc. Compumedics Ltd. Integra LifeSciences Covidien PLC Sophysa Ltd. Spiegelberg GmbH & Co. KG Hitachi Medical Corporation NeuroLogica Corp. NeuroWave Systems Inc. Noraxon U.S.A RAUMEDIC AG Sense Neuro Diagnostics BrainScope Company Inc. Others Click Here to Access a Free Sample Report of the Global Non-invasive Brain Trauma Monitoring Device Market @ Spectacular Deals Comprehensive coverage Maximum number of market tables and figures The subscription-based option is offered. Best price guarantee Free 35% or 60 hours of customization. Free post-sale service assistance. 25% discount on your next purchase. Service guarantees are available. A personalized market brief by the author. Browse More Related Reports: Canine Orthopedics Market: Canine Orthopedics Market Size, Trends and Insights By Product Type (Implants (plates, screws, pins, joint replacements), Instruments (drills, saws, fixation tools), Orthopedic Supports & Braces), By Procedure Type (Cruciate Ligament Repair, Hip and Elbow Dysplasia Treatment, Fracture Repair and Trauma Surgery), By End User (Veterinary Hospitals & Clinics, Veterinary Research Institutes, Pet Rehabilitation & Therapy Centers), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025-2034 Plastic Surgery Instruments Market: Plastic Surgery Instruments Market Size, Trends and Insights By Type (Handheld Instruments, Electrosurgical Instruments, Others), By Procedure (Cosmetic Surgery, Reconstructive Surgery), By End User (Hospitals, Dermatology Clinics, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Europe Testosterone Replacement Therapy Market: Europe Testosterone Replacement Therapy Market Size, Trends and Insights By Product Type (Injectables, Topical, Others), By Active Ingredient (Testosterone Undecanoate, Testosterone Cypionate, Testosterone Enanthate, Testosterone, Others), By End User (Hospitals, Clinics), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 US Veterinary Diagnostics Market: US Veterinary Diagnostics Market Size, Trends and Insights By Product (Consumables, Reagents, Kits, Equipment & Instruments), By Testing Category (Clinical Chemistry, Microbiology, Parasitology, Histopathology, Cytopathology, Hematology, Immunology & Serology, Imaging, Molecular Diagnostics), By Animal Type (Production Animals, Cattle, Poultry, Swine, Companion Animals, Dogs, Cats, Horses), By End-use (Reference Laboratories, Veterinarians, Animal Owners/Producers), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Biologics and Biosimilars Market: Biologics and Biosimilars Market Size, Trends and Insights By Product Type (Monoclonal Antibodies, Insulin, Recombinant Hormones, Fusion Proteins, Other Product Types), By Therapeutic Application (Oncology, Autoimmune Diseases, Diabetes, Blood Disorders, Other Therapeutic Applications), By End User (Hospitals, Clinics, Homecare Settings, Retail Pharmacies, Other End Users), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Induced Pluripotent Stem Cells Production Market: Induced Pluripotent Stem Cells Production Market Size, Trends and Insights By Process (Manual iPSC Production, Automated iPSC Production), By Workflow (Cell Culture, Cell Characterization / Analysis), By Product (Consumables & Kits, Automated Platforms), By Application (Drug Development & Discovery, Regenerative Medicine / Tissue Engineering), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Fetal Monitoring, Diagnostics and Predictive Tests Market: Fetal Monitoring, Diagnostics and Predictive Tests Market Size, Trends and Insights By Product Type (Fetal Monitoring Devices, Fetal Diagnostic Tests, Predictive Tests), By Method / Technology (Invasive monitoring, Non-invasive monitoring, Conventional diagnostics, Molecular diagnostics, Imaging-based diagnostics), By Application (Intrapartum monitoring, Antepartum monitoring, Gestational risk assessment, Pre-term birth prediction, Genetic abnormality screening), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 US Lateral Flow Assays Market: US Lateral Flow Assays Market Size, Trends and Insights By Product (Kits & Reagents, Lateral Flow Readers, Digital/Mobile Readers, Benchtop Readers), By Application (Clinical Testing, Infectious Diseases Testing, Covid-19 Testing, Mosquito Borne Disease Testing, Influenza Testing, Sexually Transmitted Infection Testing, HIV Testing, HPV Testing, Chlamydia Testing, Gonorrhea Testing, Syphilis Testing, Hepatitis, Tuberculosis, Cardiac Marker Testing, Troponin I and T Testing, CK-MB Testing, BNP and NT-proBNP Testing, Myoglobin Testing, D-Dimer Testing, Pregnancy & Fertility Testing, Pregnancy Testing, Fertility Testing, Cholesterol Testing/Lipid Profile Testing, Drugs of Abuse Testing, Veterinary Diagnostics, Food Safety & Environment Testing, Drug Development & Quality Testing), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By Test (Lateral Flow Immunoassay, Nucleic Acid Lateral Flow Assay), By End-use (Hospitals & Clinics, Diagnostic Laboratories, Home Care, Pharmaceutical & Biotechnology Companies), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 The Non-invasive Brain Trauma Monitoring Device Market is segmented as follows: By Product Type Monitoring Devices Consumables By End-User Hospitals Neurological Centres Others Click Here to Get a Free Sample Report of the Global Non-invasive Brain Trauma Monitoring Device Market @ Regional Coverage: North America U.S. Canada Mexico Rest of North America Europe Germany France U.K. Russia Italy Spain Netherlands Rest of Europe Asia Pacific China Japan India New Zealand Australia South Korea Taiwan Rest of Asia Pacific The Middle East & Africa Saudi Arabia UAE Egypt Kuwait South Africa Rest of the Middle East & Africa Latin America Brazil Argentina Rest of Latin America This Non-invasive Brain Trauma Monitoring Device Market Research/Analysis Report Contains Answers to the following Questions. Which Trends Are Causing These Developments? Who Are the Global Key Players in This Non-invasive Brain Trauma Monitoring Device Market? What are the company profiles, product information, and contact details for these key players? What Was the Global Market Status of the Non-invasive Brain Trauma Monitoring Device Market? What Was the Capacity, Production Value, Cost and PROFIT of the Non-invasive Brain Trauma Monitoring Device Market? What Is the Current Market Status of the Non-invasive Brain Trauma Monitoring Device Industry? What's the market's competition in this industry, both company-wise and country-wise? What's Market Analysis of Non-invasive Brain Trauma Monitoring Device Market by Considering Applications and Types? What Are Projections of the Global Non-invasive Brain Trauma Monitoring Device Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports? What Is Non-invasive Brain Trauma Monitoring Device Market Chain Analysis by Upstream Raw Materials and Downstream Industry? What Is the Economic Impact On Non-invasive Brain Trauma Monitoring Device Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends? What Are Market Dynamics of Non-invasive Brain Trauma Monitoring Device Market? What Are Challenges and Opportunities? What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Non-invasive Brain Trauma Monitoring Device Industry? Click Here to Access a Free Sample Report of the Global Non-invasive Brain Trauma Monitoring Device Market @ Reasons to Purchase Non-invasive Brain Trauma Monitoring Device Market Report Non-invasive Brain Trauma Monitoring Device Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors. Non-invasive Brain Trauma Monitoring Device Market report outlines market value (USD) data for each segment and sub-segment. This report indicates the region and segment expected to witness the fastest growth and dominate the market. Non-invasive Brain Trauma Monitoring Device Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region. The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled. Extensive company profiles comprise a company overview, company insights, product benchmarking, and SWOT analysis for the major market players. The Industry's current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions. Non-invasive Brain Trauma Monitoring Device Market The report encompasses a comprehensive market analysis from multiple angles, utilizing Porter's five forces analysis, and offers valuable insights into the market through the Value Chain. Reasons for the Research Report The study provides a thorough overview of the global Non-invasive Brain Trauma Monitoring Device market. Compare your performance to that of the market as a whole. Aim to maintain competitiveness while innovations from established leaders drive market growth. Buy this Premium Non-invasive Brain Trauma Monitoring Device Research Report | Fast Delivery Available - [220+ Pages] @ What does the report include? Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide analysis of the non-invasive brain trauma monitoring device market. The report covers the competitive environment of current and potential participants in the Non-invasive Brain Trauma Monitoring Device market, along with the strategic product development ambitions of those companies. This study conducts a qualitative and quantitative analysis of the market based on the component, application, and industry vertical. Additionally, the report provides comparable data for the key regions. The report provides actual market sizes and forecasts for each segment mentioned above. Who should buy this report? Participants and stakeholders worldwide Non-invasive Brain Trauma Monitoring Device market should find this report useful. The research will be useful to all market participants in the Non-invasive Brain Trauma Monitoring Device industry. Managers in the Non-invasive Brain Trauma Monitoring Device sector are interested in publishing up-to-date and projected data about the worldwide Non-invasive Brain Trauma Monitoring Device market. Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in Non-invasive Brain Trauma Monitoring Device products' market trends. Analysts, researchers, educators, strategy managers, and government organizations seek market insights to develop their plans. Request a Customized Copy of the Non-invasive Brain Trauma Monitoring Device Market Report @ About Custom Market Insights: Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains. CMI is a one-stop solution for data collection and investment advice. Our company's expert analysis digs out essential factors that help us understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey. Follow Us: LinkedIn | Twitter | Facebook | YouTube Contact Us: Joel John CMI Consulting LLC 1333, 701 Tillery Street Unit 12, Austin, TX, Travis, US, 78702 USA: +1 737-734-2707 India: +91 20 46022736 Email: support@ Web: Blog: Blog: Blog: Blog: Buy this Premium Non-invasive Brain Trauma Monitoring Device Research Report | Fast Delivery Available - [220+ Pages] @ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DocGo Announces Participation at Three Upcoming Conferences
DocGo Announces Participation at Three Upcoming Conferences

Business Wire

time3 days ago

  • Business Wire

DocGo Announces Participation at Three Upcoming Conferences

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) ('DocGo'), a leading provider of technology-enabled mobile health and medical transportation services, announced today that management will be participating in the following investor conferences in August and September: Three Part Advisors Midwest (August 26 th) Norm Rosenberg, Chief Financial Officer will participate in 1x1 meetings, and deliver a presentation on Tuesday August 26 th at 11:30 AM CT. A webcast of the event will be available on the investor relations section of DocGo's website at Cantor Global Healthcare Conference (September 3 rd) Lee Bienstock, Chief Executive Officer will hold 1x1 meetings, and participate in a fireside chat on Wednesday September 3 rd at 10:20 AM ET. A webcast of the event will be available on the investor relations section of DocGo's website at Morgan Stanley 23 rd Annual Global Healthcare Conference (September 10 th) Lee Bienstock, Chief Executive Officer will hold 1x1 meetings, and participate in a fireside chat on Wednesday September 10 th at 9:15 AM ET. A webcast of the event will be available on the investor relations section of DocGo's website at About DocGo DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo is helping to reshape the traditional four-wall healthcare system by providing high quality, highly accessible care to patients where and when they need it. DocGo's proprietary technology and relationships with a dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for municipalities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote advanced practice provider, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit To get an inside look on how the proactive healthcare revolution is helping transform healthcare by reducing costs, increasing efficiency and improving outcomes, visit

GE HealthCare (GEHC) Introduces AI-Powered Digital X-Ray System
GE HealthCare (GEHC) Introduces AI-Powered Digital X-Ray System

Yahoo

time6 days ago

  • Yahoo

GE HealthCare (GEHC) Introduces AI-Powered Digital X-Ray System

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the 11 Best Under-the-Radar Stocks to Buy Right Now. On July 24, GE HealthCare Technologies Inc. (NASDAQ:GEHC) announced the commercial launch of a new advanced digital X-ray system called Definium Pace Select ET. This floor-mounted digital X-ray system is designed to offer high-image quality and increased efficiency in highly demanding environments. hin255/ According to the report by GE HealthCare Technologies Inc. (NASDAQ:GEHC), the Definium Pace Select ET automates manual, repetitive tasks and reduces physical strain on technologists. The system leverages AI to make sure patients are positioned accurately while also providing consistent image quality across various clinical conditions. It makes the technologist's work easier and improves the experience for patients. This new system is built on GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) trusted Definium platform. It offers advanced automation and workflow features on a flexible, floor-mounted system with an elevating table, in-room exam control, and a user-friendly interface to help technologists. GE HealthCare Technologies Inc. (NASDAQ:GEHC) is a global medical technology company that provides digital infrastructure, data analytics, and decision support tools to help in the diagnosis, treatment, and monitoring of patients. While we acknowledge the potential of GEHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Revenue Growth Stocks to Buy Now and 14 Best Aggressive Growth Stocks to Buy According to Analysts. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store